Medical cannabis in the UK continues to develop as regulators, clinicians, and policymakers respond to increasing patient demand and a growing body of clinical evidence. While the legal framework remains tightly controlled, recent regulatory and operational changes are shaping how cannabis-based products for medicinal use (CBPMs) are prescribed, supplied, and governed. For clinics, prescribers, and healthcare organisations operating in this sector, staying informed about th